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Introduction
The risk of developing cardiovascular disease increases significantly in women after the onset of menopause, whether natural or surgically induced (Miller et al. 2013) . Compared with men at the same age, premenopausal women show reduced morbidity and severity of cardiovascular disease, but this advantage disappears in postmenopausal women (Wilson et al. 1985) . Human studies have confirmed a reduced incidence of cardiovascular events and mortality in women using menopausal hormone therapy for relief of menopausal symptoms (Hulley et al. 1998; Tsai et al. 2016) . The sympathetic nervous system is one of the most important peripheral mechanisms for regulation of cardiac function; some studies have confirmed that the cardiac sympathetic ganglia regulate cardiac noradrenaline (NA) content and noradrenaline transporter (NET), indicating that the cardiac sympathetic ganglia play an important role in the development of hypertension, heart failure and dilated cardiomyopathy (Moldovanova et al. 2008; Verschure et al. 2015) .
The stellate ganglion, also known as the cervicothoracic ganglion, provides ß90% of the innervation of the heart and can affect cardiac NA content and NET expression (Li et al. 2001; Mueller, 2007) . Although retrograde tracing shows no difference in the distribution of projections of the two stellate ganglia to the heart, the left and right stellate ganglia play different roles in the regulation of cardiac function (Li et al. 2001) . The right stellate ganglion is more important than the left in the maintenance of heart contraction and heart rate, whereas the left stellate ganglion plays a dominant role in the regulation of cardiac contractility (Li et al. 2001) . This difference also suggests that the left and right sides might play different roles in the development of diseases (Jovanovic et al. 2014b ). In the heart, 80-90% of the NA released is reabsorbed by the NET into the presynaptic membrane, and only a small amount is degraded or absorbed by heart muscle cells . Studies have shown that depolarization of the heart induces NA release in ovariectomized rats and that oestrogen treatment can normalize this NA release (Eskin et al. 2003) , indicating that oestrogen concentration is closely related to cardiac NA content. However, the specific mechanisms underlying this effect are not clear. In the nervous system, dopamine β-hydroxylase (DBH) catalyses the oxidative hydroxylation of dopamine to form NA (Cheng et al. 2016) . Studies investigating the effects of oestrogen on the CNS have revealed that oestrogen regulates DBH expression in important parts of the brain, such as the hypothalamus, in ovariectomized rats after oestrogen treatment for 4 weeks (Spary et al. 2009; Hart et al. 2011) . Clinical research has indicated that when using an NET-selective inhibitor, healthy women in different phases of the menstrual cycle show different responses, which indirectly indicates that oestrogen might affect heart NET function (Moldovanova et al. 2008) ; however, the mechanism underlying this effect is unknown.
Although oestrogen supplementation can significantly improve the symptoms of menopause and protect the cardiovascular system in postmenopausal women, long-term use of hormone therapy increases the risk of breast and endometrial cancers. Therefore, herbal drugs that have none of these side-effects but improve menopausal symptoms have recently drawn attention. Cimicifuga racemosa (iCR, known as Actaea racemosa), the extract of black cohosh, is widely used in the treatment of climacteric syndrome, including hot flushes, palpitations and other symptoms (Merchant & Stebbing, 2015) . Although the effect of iCR on the cardiovascular system is inconclusive, a few case reports have indicated that taking high doses of iCR may cause severe bradycardia, heart block and atypical arrhythmia (Ulbricht & Windsor, 2014) . Furthermore, a clinical study found that taking iCR simultaneously with antihypertensive drugs could affect their efficacy (Cohen & Ernst, 2010) . Therefore, researchers have speculated that iCR might inhibit NA-mediated vasoconstriction or have a direct effect on the CNS, but the specific effects of iCR on cardiac NA content are not clear (Ulbricht & Windsor, 2014) . The NA released from the heart mediates its effect by exciting the β-adrenergic receptor (β-AR; Li et al. 2009 ). There are two subtypes of cardiac β-ARs, i.e. β 1 and β 2 , and NA affinity for β 1 -AR is 30 times higher than that for β 2 -AR (Gille et al. 1985) . The β 1 -AR mediates its effects mainly through two pathways, namely the Gas protein-adenylyl cyclase-cAMP-protein kinase A pathway and the Ca 2+ -calmodulin-dependent protein kinase II (CaMK II) pathway (Chu et al. 2006) . Oestrogen Y. Liu and others reduces β 1 -AR-mediated myocardial hypertrophy and structural damage to protect the heart (Chu et al. 2006) , and it has a direct effect on CaMK II expression to reduce myocardial apoptosis ). In the present study, we investigated whether C. racemosa plays a role in the regulation of cardiovascular function and whether its effect is similar to that of oestrogen.
Methods

Ethical approval
The protocol was approved by the Ethics Committee for Animal Experimentation of the Faculty of Medicine of Peking University Health Science Center (approval no. LA2012-82). The animal experiments performed conform to the NIH guidelines and guidelines from Directive 2010/63/EU of the European parliament on the protection of animals used for scientific purposes.
Animals
Fifty healthy female Sprague-Dawley rats aged 8-10 weeks and weighing 220 ± 10 g were purchased from the Department of Laboratory Animals of Peking University Health Science Center.
Animals were housed, four per cage, in temperatureand humidity-controlled rooms with a 12 h-12 h light-dark cycle. The rats were exposed to direct light and given free access to soy-free forage and water for 2 weeks. The 40 rats were randomly divided into four groups, with 10 rats in each group, as follows: SHAM group (sham-operated group); OVX group (ovariectomized group);, E2 group (OVX group treated with estradiol valerate); and iCR group (OVX group treated with the isopropanolic extract of C. racemosa). For ovariectomy, the rats were injected I.P. with 1% sodium pentobarbital (80 mg kg −1 ; Sinopharm Chemical Reagent Company, Beijing, China) for anaesthesia, and strict asepsis was maintained. The surgical procedures were as follows. First, the rats were anaesthetized, and then an incision was made at the mid-line of the abdomen and the bilateral ovaries were revealed. In the SHAM group, the ovaries were not resected, and the same quantity of fat around the ovaries was removed instead. In the other groups, the bilateral ovaries were ligated and excised. Finally, the abdominal cavity was closed. Water containing ibuprofen (0.1 mg ml −1 ; Beijing Solarbio Science & Technology Company, Beijing, China) was provided during the 3 days after surgery to reduce postoperative pain. The rats were given 2 weeks for wound healing after the operation.
Two weeks after the operation, the rats underwent daily gavage between 08.30 and 09.30 h for 4 weeks. The determination of C. racemosa dosage was based on previous studies (Ma et al. 2011; Zhang et al. 2012; Da et al. 2015; Wang et al. 2015; Sun et al. 2015) , which demonstrated an obvious influence on function and changes in morphology without signs of side-effects. To form a uniform liquid, two types of tablets were dissolved in distilled water, and ultrasonic treatment was applied. The concentration of the estradiol was 0.2 mg ml −1 and that of C. racemosa was 12 mg ml −1 . The medication doses were as follows: SHAM group, 10 ml (kg distilled water) −1 ; OVX group, 10 ml (kg distilled water) −1 ; E2 group, 0.8 mg estradiol kg −1 (4 ml kg −1 ); and iCR group, 60 mg C. racemosa (crude drug) kg −1 (5 ml kg −1 ; Wang et al. 2015) . All rats were weighed every 3 days, and the dosage was readjusted according to the body weight.
Tissue collection
Rats were anaesthetized with an I.P. injection of 1% sodium pentobarbital (80 mg kg −1 ), followed by thoracotomy. The hearts were removed and placed in chilled (4°C) PBS (137 mM sodium chloride, 2.7 mM potassium chloride, 4.3 mM sodium phosphate dibasic and 1.4 mM potassium phosphate monobasic) for rinsing and separation of chambers. Frozen tissues were stored at −80°C until use. Stellate ganglia were isolated and fixed with 0.04 g ml paraformaldehyde at 4°C for 24 h, and the sections were cut into 5-μm-thick slices for immunohistochemical staining for DBH and NET.
Immunohistochemistry
Immunohistochemistry for DBH and NET was performed as described previously . After washing in PBS (0.01 mol l −1 , pH 7.2), the specimens were reacted with 5% normal goat serum (SP9002; Beijing Zhongshan Golden Bridge Biotechnology, Beijing, China) for 30 min at room temperature. Next, they were incubated with rabbit anti-rat DBH polyclonal antibody (1:200; SAB2701977; Sigma-Aldrich, St Louis, MO, USA) and rabbit anti-rat NET polyclonal antibody (1:400; ab41559; Abcam, Cambridge, UK) for 24 h at 4°C. After rinsing with PBS (5 min, three times), the sections were incubated with the secondary antibody (SP9001 and SP9002; Beijing Zhongshan Golden Bridge Biotechnology) conjugated to horseradish peroxidase for 3 h. After rinsing with PBS (5 min, three times), sections were reacted with avidin-biotin complex (ABC) reagent (Beijing Zhongshan Golden Bridge Biotechnology). Finally, they were reacted with 0.5 mg ml −1 3,3 -diaminobenzidine for 2-3 min. The sections were counterstained with Haematoxylin. The sections were dehydrated through a series of ethanol, cleared in xylene, and coverslipped in Permount (ZLI-9555; Beijing Zhongshan Golden Bridge Biotechnology, Beijing, China). All sections were processed in parallel with negative control sections incubated without primary antibodies. The staining was quantified using a BX51 light microscope (Olympus, Tokyo, Japan). Optical density (OD) was determined using Image-Pro Plus software, version 6.0 (Media Cybernetics, Bethesda, MD, USA).
Noradrenaline measurements
Left ventricles were homogenized in ice-cold homogenization buffer (0.2 M HClO 4 and 0.05 mM EDTA.Na 2 ). The homogenate was then centrifuged at 9500g for 60 min at 4°C, and the supernatant was further processed by collation using a filter (22 nm; MilliporeSigma, Billerica, MA, USA). Tissue samples (20 μl) were injected onto a C18 reverse-phase column (150 mm × 4.6 mm; 5 μm particles; ODS, Thermo Fisher Scientific, Waltham, MA, USA) using a Waters 717 Plus Autosampler (Waters Corporation, Milford, MA, USA), eluted using an isocratic system with the mobile phase (0.1 M NaH 2 PO 4 , 0.85 mM 1-Octanesulfonic acid sodium salt, 0.5 mM EDTA.Na 2 and 11% methyl alcohol) and then pumped using a Waters 515 HPLC pump. A Coulochem III electrochemical detector equipped with an analytical cell (ESA Biosciences, Inc., Chelmsford, MA, USA) was used to detect NA. Data were captured using Empower 2 Software (Waters Corporation).
Western blot analysis
Left ventricles were collected and homogenized. The protein concentration was determined as described previously . Extracted protein from the left ventricles (40 μg) was diluted in loading buffer [130 mmol l −1 Tris-HCl, pH 8.0, 20% (v/v) glycerol, 5% (w/v) SDS, 0.02% Bromophenol Blue and 2% dithiothreitol (DTT)] and denatured for 5 min at 95°C. The proteins were loaded onto a 10% SDS-polyvinylidene gel and then transferred to a nitrocellulose membrane at 4°C in a transfer buffer containing 20% methanol using the Bio-Rad Trans-blot electrophoretic transfer system (Bio-Rad, Hercules, CA, USA) at 220 mA for 1.5 h. After blocking in Tris-buffered saline (TBST; pH 7.4, 0.1% Tween-20) with 5% bovine serum albumin for 1 h at room temperature, the membrane was incubated with rabbit anti-rat CaMK II polyclonal antibody (1:1000; 4436; Cell Signaling, Danvers, MA, USA), rabbit anti-rat NET polyclonal antibody (1:1000; ab41559; Abcam) and rabbit anti-rat β 1 -AR polyclonal antibody (1:1000; ab3442; Abcam) overnight at 4°C. A mouse anti-rat glyceraldehyde-3-phosphate dehydrogenase (GAPDH) polyclonal antibody (1:1000; C1339; Applygen, Beijing, China) was used as the internal control. After three washes, each of 10 min, with TBST on a shaker, HRP-linked anti-mouse (1:2000; for anti-GAPDH primary antibody; Applygen) or anti-rabbit IgG (1:2000; for NET/CaMK II/β 1 -AR primary antibody; Applygen) was used as the secondary antibody. The membrane was incubated with the secondary antibody for 1 h at room temperature, followed by four washes, each of 15 min, with TBST. Bands were detected using chemiluminescence (ECL Western blot detection kit; Applygen). Images were scanned, and the intensity of the bands was calculated using Image Pro software (Media Cybernetics, Bethesda, MD, USA). The data were normalized to the loading control. The specificity of all the antibodies we used in the present study was tested in previous studies (Wang et al. 2014; Jovanovic et al. 2014a; Liu et al. 2016; Lv et al. 2016; Zhang et al. 2016; Winder et al. 2017) .
Statistical analysis
Data were analysed with SPSS version 21.0 (IBM, Chicago, IL, USA) and expressed as the mean ± SD. Significance among the four groups was determined by one-way ANOVA followed by Tukey's post hoc test. A value of P < 0.05 was considered to be statistically significant.
Results
Body weight, uterine weight and serum oestrogen concentration
After 4 weeks of treatment, the mean body weight in the OVX group (398.7 ± 37.6 g) was higher than that in the SHAM group (242.1 ± 21.73 g; P < 0.05). Oestrogen therapy was shown to suppress body weight (253.8 ± 20.44 g) significantly compared with OVX rats (P < 0.05). However, no difference was found in body weight between the OVX group and the iCR group (310.3 ± 37.1 g; Fig. 1A) .
After 4 weeks of treatment, the OVX rats (6.283 ± 1.984 pg ml −1 ) exhibited significantly lower serum oestrogen concentrations than the SHAM and E2 groups (30.21 ± 13.11 and 36.77 ± 7.613 pg ml −1 , respectively; P < 0.05). There was no marked difference in serum oestrogen concentrations between the SHAM and E2 groups. Treatment with C. racemosa, however, did not affect serum oestrogen concentration in the iCR group (8.349 ± 3.456 pg ml −1 ) compared with OVX (Fig. 1B) . Similar to serum oestrogen concentrations, the mean uterine weight was significantly lower in the OVX group (0.1147 ± 0.0338 g) than in the SHAM group (0.4001 ± 0.0602 g; P < 0.05) and the E2 group (0.3363 ± 0.1209 g; P < 0.05). No apparent difference was observed between OVX and iCR rats (Fig. 1C) .
Effects of the treatments on DBH and NET protein expression in the right and left stellate ganglia
Positive staining intensity for DBH and NET was detected in the nerve cells of the stellate ganglion. The optical density was used to compare the expression of DBH and NET between the four groups.
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Expression of DBH was significantly higher in the right stellate ganglion of the OVX group than in the SHAM, E2 and iCR groups (P < 0.05). No obvious difference was found among SHAM, E2 and iCR rats. There was no significant difference in the intensity of DBH protein expression in the left stellate ganglion in the four groups (Fig. 2) .
Expression of NET in the right stellate ganglion was significantly higher in the OVX group than in the SHAM, E2 and iCR groups (P < 0.05). No obvious difference was found among SHAM, E2 and iCR rats. There was no significant difference in NET protein expression in the left stellate ganglion in the four groups (Fig. 3) .
Effects of the treatments on NA content in the left ventricle
The NA content in the left ventricle was estimated in all four groups. The OVX rats (0.2494 ± 0.0459 μg mg −1 ) exhibited significantly lower NA content than the SHAM and E2 rats (0.4452 ± 0.1414 and 0.4527 ± 0.0736 μg mg −1 , respectively; P < 0.05). There was no marked difference between the SHAM and E2 groups. Treatment with C. racemosa, however, did not affect the NA content in the iCR group (0.2738 ± 0.0546 μg mg −1 ) compared with the OVX group (Fig. 4A) .
Effects of the treatments on NET, β 1 -AR and CaMK II protein expression in the left ventricle
Noradrenaline transporter, β 1 -AR and CaMK II were expressed in all four groups. Compared with the SHAM group, NET expression in the OVX group was significantly increased (P < 0.05). Oestrogen treatment, but not C. racemosa treatment, markedly suppressed NET expression compared with OVX rats (P < 0.05). No apparent difference was observed between OVX and iCR rats (Fig. 4B) .
In addition, Western blot analysis revealed that β 1 -AR expression was significantly higher in the OVX group than in the SHAM group (P < 0.05) and was significantly lower in the E2 and iCR groups than in the OVX group (P < 0.05). No apparent difference was observed among SHAM, E2 and iCR rats (Fig. 5A) .
Expression of CaMK II was significantly higher in the OVX group than in the SHAM group (P < 0.05) and was significantly lower in the E2 and iCR groups than in the OVX group (P < 0.05). No apparent difference was observed among SHAM, E2 and iCR rats (Fig. 5B) .
Discussion
In the present study, ovariectomy increased DBH and NET expression in the right stellate ganglion, but not the left. Oestrogen reversed all changes caused by ovariectomy. Cimicifuga racemosa did not affect left ventricular NA content and NET expression, but decreased DBH and NET expression in the right stellate ganglion and restored β 1 -AR and CaMK II protein expression in the left ventricule.
The increased weight of the ovariectomized rats could have resulted from eating more food than the SHAM and E2 group rats, through increased expression of the leptin receptor in the brain (Kimura et al. 2002) . The weight of the iCR group did not decline to normal levels, which contrasts with a previous study, where after administration of C. racemosa for 8 weeks, the weight of OVX rats gradually decreased, and after 12 weeks the weight of C. racemosa-and oestrogen-treated OVX animals was similar . The uterine wet weight and oestrogen concentration indicated that the bilateral ovariectomy was successful. In the C. racemosa-treated group, the oestrogen concentrations did not increase, indicating that C. racemosa function is not mediated by oestrogen.
Heart sympathetic projections mainly originate from the stellate ganglion, and cardiac NA concentrations are affected by the stellate ganglion, as evidenced by the results of a previous study, where bilateral stellate ganglionectomy in rats reduced cardiac NA content by 89-100% (Pardini et al. 1990; Esfahanian et al. 2008) . In the present study, we found that in the absence of oestrogen, there was asymmetry in the expression of NA synthase, DBH and NET between the left and right stellate ganglion. These results indicate that the two stellate ganglia might play different roles in the regulation of cardiac function. Asymmetric structure and function of the left and right stellate ganglia has also been reported by Vaseghi et al. (2012) , who found that injecting nerve growth factor into the right stellate ganglion had anti-arrhythmic effects, whereas injecting it into the left ganglion led to drug-induced arrhythmia, and that stimulation of the left stellate ganglion increased the NA concentration in the synaptic cleft by 200%, whereas stimulating the right side increased the concentration by 260%. Moreover, previous studies have demonstrated that stimulation of the right side of the sympathetic chain leads to a more obvious change in heart rate than stimulation of the left side (Winter et al. 2012) . Although the effect on cardiac NA synthesis of the stellate ganglion could not be determined unambiguously in our animal model, in socially isolated rats, tyrosine hydroxylase and NET expression in the right stellate ganglion was previously shown to be significantly increased, whereas expression of tyrosine hydroxylase protein was decreased in the left stellate ganglion, suggesting that the two ganglia play different roles in neuromodulation under pressure (Jovanovic et al. 2014b) . On the basis of these results, we speculate that the right stellate ganglion plays a more important role than the left stellate ganglion in heart changes caused by low oestrogen concentration, but the specific mechanism underlying this effect needs further research. Left ventricular NET protein is first synthesized in the stellate ganglion and then transferred from the neuronal axon to the cardiac nerve terminals. In the ovariectomized group, although stellate ganglion DBH and NET expression and left ventricular NET content were significantly increased, left ventricular NA content was not restored to normal levels, suggesting that NET function may be impaired, the number of NET binding sites may be decreased or NA release may be increased in these rats, leading to decreased NA content (Eskin et al. 2003; Wehrwein et al. 2013) . This mechanism might be the possible pathological basis for cardiovascular disease in menopausal women. Previous studies also found a significant increase in NA release upon cardiac depolarization in ovariectomized rats, and this release was restored to normal levels after oestrogen supplementation (Eskin et al. 2003) . Moreover, in several other diseases, such as hypertension and heart failure, increased NA release is often associated with a reduced tissue NA concentration and inhibition of peripheral catecholamine reuptake (Hasking et al. 1986; Goldstein et al. 2002) . Release of catecholamine and its oxidation products into the synaptic cleft can have a direct toxic effect on myocardial cells and may also be involved in the process of cardiac hypertrophy (Kassim et al. 2008; Gavrilovic et al. 2012) . Based on these results and those reported in the literature, we hypothesized that oestrogen not only regulates the expression of stellate ganglion NA-related proteins, but also directly affects the NET uptake function of the left ventricle (Moldovanova et al. 2008) . However, other uncharacterized pathways that restore the NET expression of the left ventricular wall cannot be excluded.
Cimicifuga racemosa treatment improved the expression of NA-related proteins in the right stellate ganglion, but did not affect the NA content of the heart, suggesting that the oestrogen deficiency-induced decrease in the NA content of the left ventricle might have been caused by multiple factors. Although the dose used in rats was comparable to that in humans, the effectiveness of C. racemosa could be different depending on the different pharmacodynamics of the drug in rats and humans.
Previous studies have demonstrated that ovariectomy increases β 1 -AR expression and that oestrogen supplementation attenuates this increased expression (Chu et al. 2006; Wu et al. 2008) , which is consistent (Hook & Means, 2001) . These proteins play a role in myocardial apoptosis, ventricular hypertrophy and heart failure (Zhang & Brown, 2004) . Previous studies have found that oestrogen not only reduces β 1 -AR synthesis in ovariectomized rats, but also directly affects CaMK II by reducing its expression , which is consistent with our results.
Cimicifuga racemosa can also restore the expression of β 1 -AR and CaMK II to normal values. Given that little research on the effect of C. racemosa on the heart was available, we investigated the effect of C. racemosa on other organs to determine whether C. racemosa has a direct effect on oestrogen receptors or on these two proteins. As early as 1985, Jarry et al. (1985) found that the isopropanol extract of black cohosh contained oestrogen isoflavone analogues and that the action of black cohosh was mainly achieved by binding competitively to oestrogen receptors. Consumption of C. racemosa, the extract of black cohosh, can significantly improve the symptoms of menopause in a similar manner to oestrogen supplementation. Additionally, C. racemosa and oestrogen have the same effect on the neurotransmitters noradrenaline and serotonin in some areas of the CNS, such as the preoptic anterior hypothalamus and locus coeruleus . However, in recent years, studies have increasingly shown that the effect of C. racemosa is unrelated to the oestrogen receptor. All extracts of black cohosh have been shown not to contain substances that can bind to oestrogen receptors (Wuttke et al. 2014) , and there is no evidence showing that extracts of black cohosh can directly bind to oestrogen receptor α or β (Beck et al. 2003; Jarry et al. 2003) . Clinical studies found that black cohosh did not increase mammary gland density or increase breast cell proliferation (Hirschberg et al. 2007 ), but also had no effect on the thickness of the endometrium . However, it is still thought that this does not exclude a role of C. racemosa in a non-genetic mechanism similar to that of oestrogen (Wuttke et al. 2014) . Additionally, C. racemosa has no effect on organs not considered to be regulated by oestrogen, such as the lungs and kidneys (Seidlova-Wuttke et al. 2009 ). Some studies have even found that black cohosh extract can inhibit the proliferation of oestrogen-dependent and non-estrogen-dependent human breast cancer cell lines (Hostanska et al. 2004) , but the corresponding effect was limited in animal experiments (Freudenstein et al. 2002) . However, the specific mechanism underlying the effect of C. racemosa needs further study.
Conclusion
In summary, our experiments show that oestrogen not only reduces the synthesis of DBH and NET by the right stellate ganglion, but also maintains cardiac NA and NET content, and that C. racemosa treatment reduces the expression of DBH and NET in the right stellate ganglion but does not have an effect on the NA content of the heart. Based on these results, we speculate that the decreased NA content induced by oestrogen deficiency in the left ventricle is probably not entirely compensated by the increased expression of DBH and NET in the right stellate ganglion. However, we cannot exclude other pathological changes, such as reduced cardiac NET reuptake resulting from functional damage; the process might be influenced by multiple factors. Furthermore, we found that C. racemosa decreases the expression of β 1 -AR and CaMK II, but does not have an effect on the NET and NA content of the heart. These results might show potential effects of C. racemosa on the cardiovascular system.
